How to Buy Synergy Chc Stock
Synergy Chc Corp
Synergy Chc is a medical distribution company located in Maine, United States, which is part of the Healthcare sector, and is traded under the ticker SNYR on the NASDAQ exchange.
Synergy Chc stock last closed at $1.95, up 2.63% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Medical Distribution industry by N/A percentage points. Synergy Chc stock is currently +50% from its 52-week low of $1.30, and -80.5% from its 52-week high of $10.00.
There are currently 8.75M shares of SNYR outstanding. The market capitalization of SNYR is $17.07M. In the past 24 hours, 40,524 SNYR shares were traded.
How to Buy Synergy Chc Stock
Not sure how to invest in Synergy Chc stock? Here's how.
- Figure out where to buy Synergy Chc stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Synergy Chc stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Select your payment method and add your information.
- Analyze Synergy Chc stock: The Synergy Chc ticker symbol is SNYR. Is Synergy Chc stock a good investment? Should you buy shares of SNYR? How do SNYR's underlying business fundamentals look? Do top analysts think Synergy Chc is a good buy? Why has SNYR's stock price moved recently? (Hint: Our stock research tools can help you evaluate if SNYR is a good stock to buy).
- Execute your SNYR trade: Decide if you will purchase SNYR shares at the current market price or use a limit order to buy SNYR shares at a particular price.
- Get notifications regarding your SNYR investment: Create a watchlist to important notifications about your new investment in Synergy Chc stock.
Step 1: Figure out where to buy Synergy Chc stock
You need an online brokerage account to access the NASDAQ market and buy SNYR shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Healthcare, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal details so you can invest in SNYR stock today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to open a new brokerage account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have created your account on app for investing, your next step is to transfer the money for your investment:
Watch this video walkthrough for more details depositing funds into your new brokerage account.
Step 4: Analyze Synergy Chc stock
After you have identified the best place to buy Synergy Chc stock, it's absolutely critical to analyze their stock before you buy, so you can understand the risk as well as the opportunity.
Synergy Chc stock data
Synergy Chc Due Diligence Score
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on SNYR's stock page.
What is the fair value of SNYR stock?
Analysts use many financial metrics, analyses, models, and charts to gauge SNYR's fair value.
Using relative valuations ratios:
- SNYR may be undervalued based on its P/E ratio of 6.96x, relative to Medical Distribution industry P/E ratio of 33.25x
- SNYR could be undervalued based on its PEG ratio of 0.1x
You can do more valuation research on SNYR's stock here.
SNYR Financial Health
Passed Financial Due Diligence Checks:
- SNYR has $5.16M in cash and short term investments. This is enough to cover its annual cash burn of $4.80M.
- SNYR has cash burn of 4803390. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the SNYR balance sheet.
Failed Financial Due Diligence Checks:
- SNYR debt to equity ratio of -1.98 is negative.
- Total SNYR debt is still negative.
- SNYR profit margin has gone down from 14.8% to 6.1% in the past year.
- There are more short-term liabilities than short-term assets on the SNYR balance sheet.
Is it a good time to buy SNYR stock, according to analysts?
Out of 1 Wall Street analysts who give recommendations on SNYR, the consensus analyst rating on Synergy Chc is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Synergy Chc stock forecast page.
Metrics for Advanced SNYR Traders
SNYR Performance Numbers
Last year, SNYR earnings were $2.12M. In the last 1 years, SNYR's earnings have increased by -67.44% per year. This was slower than the Medical Distribution industry average of 59.52%.
Last year, SNYR revenue was $34.83M. Over the last 2 year, SNYR's revenue has gone up by -4.77% per year. This was slower than the Medical Distribution industry average of 9.08%.
Learn more about SNYR's earnings and revenue performance here.
Who is buying/selling SNYR?
In the last year, executives and large shareholders at SNYR have bought more shares than they have sold.
Jack Ross, CEO and Chairman of SNYR, was the latest SNYR insider to buy. They bought $1,200.00 worth of SNYR stock on Feb 21, 2025.
Research more about who owns SNYR stock here.
Does SNYR provide a stable income stream?
No, Synergy Chc doesn't provide an income stream by paying out dividends.
What do other traders have to say about SNYR?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your SNYR trade
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually fine. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a specific price, place a limit order.
Click the Open button and eToro will place your order.
If you require additional info about buying stocks on eToro, click the how to video below:
Step 6: Get notifications regarding your SNYR investment
Now that you own some SNYR stock, you'll want to stay up-to-date on your new stock purchase.
Put SNYR on a watchlist to track the latest developments regarding your SNYR stock.
SNYR Feed
How to Buy Stock in Synergy Chc
To summarize, here are the 6 steps for buying Synergy Chc stock:
- Figure out where to buy Synergy Chc stock
- Create a brokerage account
- Fund your brokerage account
- Analyze Synergy Chc stock
- Execute your SNYR trade
- Get notifications regarding your SNYR investment
If you require a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep track of your investment in Synergy Chc, get started below.
Trending "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.